维普中文期刊产品整合服务
8篇 您的检索式:作者名="Budinski D"
    题名 作者 年代 出处 被引量
1Paricaleitol (19- nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25- dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells 显示文摘Sochorova K Budinsky V Rozkova D 2009Clin Immunol2009,133,1:1
2Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia显示文摘Budinski D Ameson V Hounslow N 2009Clinical Lipidology2009,4,3:1
3Pitavastatin compared with Atorvastatin in primary hypercholesterolemia or combined dyslipidemia显示文摘Budinski D Arneson V Hounslow N 2009Future Lipidol2009,4,3:1
4Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25- dihydroxyvitamin D3 ) exert potent immunomodulatory effects on dendritic ceils and inhibit induction of antigen-specific T cells 显示文摘SOCHOROVA K BUDINSKY V ROZKOVA D 2009Clin lmmunol2009,133,1:1
5Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia显示文摘Ose L Budinski D Hounslow N Arneson V 2010Atherosclerosis2010,210,1:1
6Comparative long-term efficacy and tolerability of pitavastatin 4mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia显示文摘Gumprecht J Gosho M Budinski D 2011Deabetes Obes Metab2011,13,11:1
7Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia 显示文摘Gumpreeht J Gosho M Budinski D Diabetes Obes Metab0,13,11:1
8Pitavastatin compared with atorvastatin in primary hypercholes- terolemia or combined dyslipidemia显示文摘Budinski D Arneson V Hounslow N 2009Clinical Lipidol- ogy2009,4,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费